Covid: Pfizer says antiviral pill 89% effective in high risk cases
Covid: Pfizer says antiviral pill 89% effective in high risk cases An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest. The drug - called Paxlovid - is aimed at the elderly and others at high risk of severe disease.covid-19medicinelink